COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Pathway Therapeutics is a San Francisco–based drug discovery and development company developing selective PI3K and mTOR inhibitors, including PWT33597 (PI3Kα/mTOR dual inhibitor) and a PI3Kδ selective program.
